NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Dosentrx

Dosentrx

Private
Tel AvivHealthcare & Life Scienceshttps://www.dosentrx.com/

Last Round

Seed Round

Mar 19, 2026

Company Overview

Dosentrx is a healthtech company that developed ReX, a therapy management platform and smart pill-dispensing device intended to improve medication adherence for specialty treatments.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Patient Engagement, Vertical SaaS

Business Model

B2B2C

Customer Profile

Services & Consulting, Hardware + Subscription

AI Layer

Application

Keywords

medication managementmedication adherencesmart pill dispenserdigital healthremote patient monitoringRPMspecialty pharmacyconnected medical devicehealth IoTpatient engagementmedication compliancemedtechvertical SaaSoncology supportcare management

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Dosentrx Comps

Public and private peers based on sector, stage, and business model.

Dosentrx comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Dosentrx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundMar 19, 2026
GrantFeb 10, 2020
AcceleratorJun 4, 2019

Key People

Founding team and executive leadership

Alan Paz

Chief Technical Officer, Co-Founder

Founding Team

Ilan Paz

CTO

Executive Team

Liron Levi-Gabay 🇮🇱

Fractional CFO GC

Executive Team

Dosentrx Investors

Notable investors and investment history

Dosentrx Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Dosentrx Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Dosentrx's valuation, stock price, and market status.

Firmographic Details

HeadquartersTel Aviv
Employee Range37
Year Founded2011
Last FundingMar 19, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.